- Home
- KZR vs HHS Comparison
KZR vs HHS Comparison
Compare KZR & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZR
- HHS
- Stock Information
- Founded
- KZR 2015
- HHS 1923
- Country
- KZR United States
- HHS United States
- Employees
- KZR N/A
- HHS N/A
- Industry
- KZR Biotechnology: Pharmaceutical Preparations
- HHS Advertising
- Sector
- KZR Health Care
- HHS Consumer Discretionary
- Exchange
- KZR Nasdaq
- HHS Nasdaq
- Market Cap
- KZR 54.1M
- HHS 52.3M
- IPO Year
- KZR 2018
- HHS N/A
- Fundamental
- Price
- KZR $6.43
- HHS $5.61
- Analyst Decision
- KZR Hold
- HHS
- Analyst Count
- KZR 2
- HHS 0
- Target Price
- KZR $11.00
- HHS N/A
- AVG Volume (30 Days)
- KZR 61.0K
- HHS 24.3K
- Earning Date
- KZR 11-12-2024
- HHS 11-14-2024
- Dividend Yield
- KZR N/A
- HHS N/A
- EPS Growth
- KZR N/A
- HHS N/A
- EPS
- KZR N/A
- HHS N/A
- Revenue
- KZR N/A
- HHS $187,604,000.00
- Revenue This Year
- KZR N/A
- HHS N/A
- Revenue Next Year
- KZR N/A
- HHS $4.05
- P/E Ratio
- KZR N/A
- HHS N/A
- Revenue Growth
- KZR N/A
- HHS N/A
- 52 Week Low
- KZR $5.20
- HHS $5.31
- 52 Week High
- KZR $11.40
- HHS $8.87
- Technical
- Relative Strength Index (RSI)
- KZR 28.75
- HHS 37.55
- Support Level
- KZR $6.80
- HHS $5.52
- Resistance Level
- KZR $7.04
- HHS $5.98
- Average True Range (ATR)
- KZR 0.24
- HHS 0.26
- MACD
- KZR -0.06
- HHS 0.03
- Stochastic Oscillator
- KZR 0.00
- HHS 32.58
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.